Abstract:Objective The study examined the influence of the COVID-19 pandemic in India on variation in clinical features, management and in-hospital outcomes in patients undergoing percutaneous coronary intervention (PCI). Design Prospective registry-based observational study. Setting A tertiary care hospital in India participant in the American College of Cardiology CathPCI Registry. Participants 7089 successive patients who underwent PCI from April 2018 to March 2023 were enrolled (men 5627, women 1462). Details of risk factors, clinical presentation, coronary angiography, coronary interventions, clinical management and in-hospital outcomes were recorded. Annual data were classified into specific COVID-19 periods according to Government of India guidelines as pre-COVID-19 (April 2018 to March 2019, n=1563; April 2019 to March 2020, n=1594), COVID-19 (April 2020 to March 2020, n=1206; April 2021 to March 2022, n=1223) and post-COVID-19 (April 2022 to March 2023, n=1503). Results Compared with the patients in pre-COVID-19 and post-COVID-19 periods, during the first COVID-19 year, patients had more hypertension, non-ST elevation myocardial infarction (NSTEMI), lower left ventricular ejection fraction (LVEF) and multivessel coronary artery disease (CAD). In the second COVID-19 year, patients had more STEMI, lower LVEF, multivessel CAD, primary PCI, multiple stents and more vasopressor and mechanical support. There were 99 (1.4%) in-hospital deaths which in the successive years were 1.2%, 1.4%, 0.8%, 2.4% and 1.3%, respectively (p=0.019). Compared with the baseline year, deaths were slightly lower in the first COVID-19-year (age-sex adjusted OR 0.68, 95% CI 0.31 to 1.47) but significantly more in the second COVID-19-year (OR 1.97, 95% CI 1.10 to 3.54). This variation attenuated following adjustment for clinical presentation, extent of CAD, in-hospital treatment and duration of hospitalisation. Conclusions In-hospital mortality among patients with CAD undergoing PCI was significantly higher in the second year of the COVID-19 pandemic in India and could be one of the reasons for excess deaths in the country. These patients had more severe CAD, lower LVEF, and more vasopressor and mechanical support and duration of hospitalisation.

What problem does this paper attempt to address?

This paper aims to explore the changes in clinical manifestations, angiography, interventions and hospitalization outcomes of patients with coronary artery disease (CAD) in India during the COVID - 19 pandemic. Specifically, the study evaluated the impact of the pandemic on these patients by analyzing data from 7,089 patients who underwent percutaneous coronary intervention (PCI) in a tertiary hospital in India from April 2018 to March 2023. ### Main research questions 1. **The impact of the COVID - 19 pandemic on the clinical manifestations of CAD patients**: The study examined whether the clinical characteristics of CAD patients changed during the pandemic, such as the incidences of hypertension, non - ST - segment - elevation myocardial infarction (NSTEMI), left ventricular ejection fraction (LVEF) and multi - vessel coronary artery disease (CAD). 2. **The impact of the COVID - 19 pandemic on angiography and interventions in CAD patients**: The study analyzed the changes in angiography results and PCI procedures in CAD patients during the pandemic, including the number of stents used, and the use of drugs and mechanical support. 3. **The impact of the COVID - 19 pandemic on the hospitalization outcomes of CAD patients**: The study evaluated the changes in in - hospital mortality and other hospitalization outcomes of CAD patients during the pandemic. ### Research design - **Research type**: Prospective registered observational study. - **Research site**: A tertiary hospital in India, participating in the American College of Cardiology CathPCI registry program. - **Research subjects**: 7,089 patients who underwent continuous PCI from April 2018 to March 2023. - **Data classification**: According to the Indian government guidelines, the annual data were divided into three periods: pre - pandemic (April 2018 - March 2019, April 2019 - March 2020), during the pandemic (April 2020 - March 2021, April 2021 - March 2022) and post - pandemic (April 2022 - March 2023). ### Main findings - **The first year of the pandemic**: The proportions of hypertension, NSTEMI, low LVEF and multi - vessel CAD were higher among patients. - **The second year of the pandemic**: The proportions of STEMI, low LVEF, multi - vessel CAD, primary PCI, multiple stents and the use of more drugs and mechanical support were higher among patients. The in - hospital mortality rate increased significantly (2.4%), and the adjusted age - and - sex - adjusted odds ratio (OR) was 1.97 (95% CI 1.10 - 3.54). - **Length of hospital stay**: The average and median lengths of hospital stay in the first and second years of the pandemic increased significantly. ### Conclusions - **In - hospital mortality**: In the second year of the pandemic, the in - hospital mortality rate of CAD patients increased significantly, which may be one of the reasons for excess deaths in India during the epidemic. - **Patient characteristics**: These patients were more severely ill, had lower LVEF, required more drug and mechanical support, and had a longer hospital stay. ### Discussion - **Comparison with other studies**: Similar studies in the UK, Europe and the United States also reported serious disruptions in acute coronary care and cardiovascular services during the COVID - 19 pandemic, as well as delays in seeking medical treatment after acute coronary events. - **Possible reasons**: In addition to the shortage of medical resources, factors such as poor control of cardiovascular risk factors, lifestyle changes and increased psychological stress during the pandemic may also lead to the deterioration of CAD patients' conditions. ### Limitations - **Single - center study**: The data were from a tertiary hospital and may not be nationally representative. - **Sample bias**: Approximately 40% of the patients in the study had private health insurance, which was inconsistent with the insurance coverage rate of the overall Indian population. - **Lack of certain data**: The study did not include data such as the time from symptom onset to hospital arrival, door - to - needle or door - to - balloon time, so it was unable to comment on the situation of delayed medical visits. In conclusion, this study provides important insights into the impact of the COVID - 19 pandemic on CAD patients in India, highlighting the challenges faced by the medical system during the pandemic and its impact on patient health.

Influence of COVID-19 pandemic in India on coronary artery disease clinical presentation, angiography, interventions and in-hospital outcomes: a single centre prospective registry-based observational study

Safety measures for COVID-19 do not compromise the outcomes of patients undergoing primary percutaneous coronary intervention: a single center retrospective study

[Regional Vascular Center in a COVID-19 pandemic: what changed in 2020 compared to 2019 in patients with ST Elevation Myocardial Infarction?]

Clinical outcomes for patients with cardiovascular diseases before, during, and after the COVID19 pandemic. A pooled analysis of 600.000 patients.

Increased coronary artery disease severity in patients undergoing invasive diagnostics during the COVID-19 pandemic

Pattern of Admission, Management and In hospital Outcome of ACS Patients during COVID-19 pandemic - A study in Tertiary Care hospital

Impact of SARS-CoV-2 Outbreak on Emergency Department Presentation and Prognosis of Patients with Acute Myocardial Infarction: A Systematic Review and Updated Meta-Analysis

Trends and Outcomes of Acute Myocardial Infarction During the Early COVID-19 Pandemic in the United States: A National Inpatient Sample Study

Prevalence of coronary artery disease among COVID-19 patients: a systematic review and meta-analysis

Management strategies and outcomes of acute coronary syndrome (ACS) during Covid-19 pandemic

Short Term Outcomes and Treatment Intensity of Major Cardiovascular Emergencies During the SARS-CoV2 Pandemic in Germany

Increased mortality and worse cardiac outcome of acute myocardial infarction during the early COVID‐19 pandemic

Impact of the COVID-19 pandemic on in-hospital mortality in cardiovascular disease: a meta-analysis

Impact of the COVID‐19 pandemic on provision of interventional cardiology and cardiac surgery services in Australia: a review of Medicare claims data

Impact of COVID-19 pandemic on STEMI undergoing primary PCI treatment in Beijing, China

Changes in the investigation and management of suspected myocardial infarction and injury during COVID-19: a multi-centre study using routinely collected healthcare data

Impact of hypertension on mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty: insights from the international multicenter ISACS-STEMI registry

Initial Findings From the North American COVID-19 Myocardial Infarction Registry

Angiographic characteristics of Patients with STEMI and COVID-19 – Insights from NACMI Registry

The impact of coronavirus disease 2019 on acute coronary syndrome: Differences between epidemic waves

CT coronary angiography and COVID-19: inpatient use in acute chest pain service